A pair of polls show near-universal and growing opposition to migration among New York communities amid the chaos and diversity created by D.C. pro-migration policies.
Neuralink has received the green light to initiate recruitment for its inaugural human clinical trial, dubbed the PRIME Study (Precise Robotically Implanted Brain-Computer Interface).